The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis

Abstract Background Multi-matrix mesalazine (MMX) is an important treatment for ulcerative colitis (UC); however, it is often excreted intact, which increases the risk of relapse. This study aimed to clarify the risk factors for insoluble MMX excretion. Methods The subjects were 102 UC patients who...

詳細記述

書誌詳細

主要な著者:	Ohtaki Yuichiro, Uchiyama Kan, Kamiya Hirotaka, Moriizumi Eri, Yamada Moe, Aoki Yuma, Watanabe Toshimune, Kiryu Sachie, Suzuki Sizuka, Matsumoto Yoshihiro, Ito Zensho, Ohkusa Toshifumi, Koido Shigeo, Saruta Masayuki
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2022-08-01
シリーズ:	BMC Gastroenterology
主題:	Ulcerative Colitis MMX Bristol Stool Form Scale 5-ASA Adherence Multi-matrix system mesalazine
オンライン･アクセス:	https://doi.org/10.1186/s12876-022-02474-9
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!